{"id":"continue-the-pi-r-containing-haart","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Ritonavir works by binding to the protease enzyme of the HIV-1 virus, preventing it from processing viral proteins and replicating the virus. This results in a decrease in the viral load and an increase in the CD4 cell count. Ritonavir is often used in combination with other antiretroviral medications to achieve optimal treatment outcomes.","oneSentence":"Ritonavir is a protease inhibitor used to treat HIV-1 infection by preventing the replication of the virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:07:31.101Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of HIV-1 infection in combination with other antiretroviral medications"}]},"trialDetails":[{"nctId":"NCT01792570","phase":"PHASE3","title":"DRV/r + RPV QD: Efficacy and Toxicity Reduction","status":"COMPLETED","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2014-09-30","conditions":"Human Immunodeficiency Virus","enrollment":37}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["the drugs will depend on the successful regimen."],"phase":"phase_3","status":"active","brandName":"continue the PI/r-containing HAART.","genericName":"continue the PI/r-containing HAART.","companyName":"ASST Fatebenefratelli Sacco","companyId":"asst-fatebenefratelli-sacco","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ritonavir is a protease inhibitor used to treat HIV-1 infection by preventing the replication of the virus. Used for Treatment of HIV-1 infection in combination with other antiretroviral medications.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}